NDC 75987-031

Vimovo

Naproxen And Esomeprazole Magnesium

Vimovo is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Horizon Therapeutics Usa, Inc.. The primary component is Naproxen; Esomeprazole Magnesium.

Product ID75987-031_141883fd-85e4-4d33-afe8-8af811700939
NDC75987-031
Product TypeHuman Prescription Drug
Proprietary NameVimovo
Generic NameNaproxen And Esomeprazole Magnesium
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2010-07-06
Marketing CategoryNDA / NDA
Application NumberNDA022511
Labeler NameHorizon Therapeutics USA, Inc.
Substance NameNAPROXEN; ESOMEPRAZOLE MAGNESIUM
Active Ingredient Strength375 mg/1; mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 75987-031-04

60 TABLET, DELAYED RELEASE in 1 BOTTLE (75987-031-04)
Marketing Start Date2010-07-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 75987-031-04 [75987003104]

Vimovo TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA022511
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-07-06

Drug Details

Active Ingredients

IngredientStrength
NAPROXEN375 mg/1

OpenFDA Data

SPL SET ID:baa47781-7151-4c75-a9a2-d2eac0a7d55e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 994008
  • 994010
  • 994005
  • 994007
    • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
    • UPC Code
  • 0375987031041
  • 0375987030044
    • NUI Code
  • N0000000160
  • N0000175722
  • N0000175721

    • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Proton Pump Inhibitor [EPC]
    • Proton Pump Inhibitors [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]

    Medicade Reported Pricing

    75987003104 VIMOVO DR 375-20 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Vimovo" or generic name "Naproxen And Esomeprazole Magnesium"

    NDCBrand NameGeneric Name
    75987-030VimovoNaproxen and Esomeprazole Magnesium
    75987-031VimovoNaproxen and Esomeprazole Magnesium
    0378-4385Naproxen and Esomeprazole Magnesiumnaproxen and esomeprazole magnesium
    0378-4386Naproxen and Esomeprazole Magnesiumnaproxen and esomeprazole magnesium
    27241-202Naproxen and esomeprazole magnesiumNaproxen and esomeprazole magnesium
    27241-203Naproxen and esomeprazole magnesiumNaproxen and esomeprazole magnesium
    55111-289Naproxen and esomeprazole magnesiumNaproxen and esomeprazole magnesium
    55111-701Naproxen and esomeprazole magnesiumNaproxen and esomeprazole magnesium
    70748-215NAPROXEN AND ESOMEPRAZOLE MAGNESIUMNAPROXEN AND ESOMEPRAZOLE MAGNESIUM
    70748-216NAPROXEN AND ESOMEPRAZOLE MAGNESIUMNAPROXEN AND ESOMEPRAZOLE MAGNESIUM

    Trademark Results [Vimovo]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VIMOVO
    VIMOVO
    77726998 3914867 Dead/Cancelled
    AstraZeneca UK Limited
    2009-05-01
    VIMOVO
    VIMOVO
    77670350 3941225 Live/Registered
    AstraZeneca UK Limited
    2009-02-13
    VIMOVO
    VIMOVO
    77475260 not registered Dead/Abandoned
    AstraZeneca UK Limited
    2008-05-15
    VIMOVO
    VIMOVO
    75809739 2629729 Dead/Cancelled
    Zeneca Limited
    1999-09-28
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.